Literature DB >> 8197142

Gamma interferon activates a previously undescribed Ca2+ influx in T lymphocytes from patients with multiple sclerosis.

G Martino1, E Clementi, E Brambilla, L Moiola, G Comi, J Meldolesi, L M Grimaldi.   

Abstract

Multiple sclerosis (MS) is an immune-mediated demyelinating disease of the central nervous system. The etiology of the disease is still unknown. Activated T lymphocytes are considered essential in mediating the inflammatory process leading to demyelination in MS. They operate through a complex network of cytokines among which gamma interferon (gamma-IFN) plays a key role. Here we report that exposure to gamma-IFN of T lymphocytes from patients with MS activates, by a protein kinase C-mediated pathway, a previously undescribed gamma-IFN-activated Ca2+ influx, functionally coupled to the gamma-IFN receptor. The influx mainly expressed by CD4+ T lymphocytes, was found in 12 of 15 (80%) patients with clinically active MS and in 14 of 30 (46%) patients with stable MS. The influx was found in only 3 of 24 (12%) control patients and in none of the 15 healthy subjects studied. Our results document the appearance in MS lymphocytes of a gamma-IFN-activated, protein kinase C-dependent, Ca2+ influx that might be due to the expression of a new cation-specific plasmalemma channel. This finding suggests that at least part of gamma-IFN's contribution to the pathogenesis of MS is exerted through a Ca(2+)-dependent regulation of T lymphocyte activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8197142      PMCID: PMC43881          DOI: 10.1073/pnas.91.11.4825

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Generation and characterization of monoclonal antibodies specific for the human IFN-gamma receptor.

Authors:  K C Sheehan; J Calderon; R D Schreiber
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

2.  Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase.

Authors:  T Tamaoki; H Nomoto; I Takahashi; Y Kato; M Morimoto; F Tomita
Journal:  Biochem Biophys Res Commun       Date:  1986-03-13       Impact factor: 3.575

Review 3.  Diagnosis and classification of multiple sclerosis.

Authors:  W I McDonald; A M Halliday
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

4.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

5.  In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta.

Authors:  R A Rudick; C S Carpenter; D L Cookfair; V K Tuohy; R M Ransohoff
Journal:  Neurology       Date:  1993-10       Impact factor: 9.910

6.  Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro.

Authors:  K W Selmaj; C S Raine
Journal:  Ann Neurol       Date:  1988-04       Impact factor: 10.422

7.  Interferon-gamma-induced transcriptional activation is mediated by protein kinase C.

Authors:  X D Fan; M Goldberg; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

8.  Exacerbations of multiple sclerosis in patients treated with gamma interferon.

Authors:  H S Panitch; R L Hirsch; A S Haley; K P Johnson
Journal:  Lancet       Date:  1987-04-18       Impact factor: 79.321

9.  Interferon-gamma modulates protein kinase C activity in murine peritoneal macrophages.

Authors:  T A Hamilton; D L Becton; S D Somers; P W Gray; D O Adams
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

10.  Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.

Authors:  D H Miller; P Rudge; G Johnson; B E Kendall; D G Macmanus; I F Moseley; D Barnes; W I McDonald
Journal:  Brain       Date:  1988-08       Impact factor: 13.501

View more
  5 in total

1.  Interferon-gamma induced increases in intracellular calcium in T lymphocytes from patients with multiple sclerosis precede clinical exacerbations and detection of active lesions on MRI.

Authors:  G Martino; M Filippi; V Martinelli; E Brambilla; C Gobbi; G Comi; L M Grimaldi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-09       Impact factor: 10.154

2.  Interferon-gamma activated calcium influx in peripheral blood lymphocytes from patients with primary and secondary progressive multiple sclerosis.

Authors:  G Martino; E Brambilla; M Filippi; V Martinelli; B Colombo; M Rodegher; G Comi; L M Grimaldi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

3.  Patterns of disease activity in multiple sclerosis patients: a study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups.

Authors:  M Rovaris; D Barnes; N Woodrofe; G H du Boulay; J W Thorpe; A J Thompson; W I McDonald; D H Miller
Journal:  J Neurol       Date:  1996-07       Impact factor: 4.849

4.  Down-regulation of Myelin Gene Expression in Human Oligodendrocytes by Nitric Oxide: Implications for Demyelination in Multiple Sclerosis.

Authors:  Malabendu Jana; Kalipada Pahan
Journal:  J Clin Cell Immunol       Date:  2013-07-31

Review 5.  Chondroitin sulfate proteoglycans in the nervous system: inhibitors to repair.

Authors:  Justin R Siebert; Amanda Conta Steencken; Donna J Osterhout
Journal:  Biomed Res Int       Date:  2014-09-18       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.